Synthon

Synthon is a pharmaceutical company specialized in the development, manufacturing and commercialization of complex generic pharmaceuticals globally. Founded in 1991, it describes itself as a leading B2B player in the generics industry, combining research and development, manufacturing and commercialization. Its global headquarters is in Nijmegen, The Netherlands, and it operates in numerous markets worldwide, including the United States, European Union, Russia and Asia.

Synthon was founded in 1991 and states that it has been a leader in the development, manufacture and commercialization of complex generics for more than three decades. It describes itself as having become the leading B2B player in the generics industry, with a focus on innovation, science and intellectual property to drive differentiation. Its global headquarters is in Nijmegen, The Netherlands, and its offices are located in Argentina, Chile, Czech Republic, South Korea, Mexico, the Netherlands, and Spain. In 2025, Synthon was awarded a Bronze medal for sustainable performance of its business by EcoVadis.

Science-driven B2B leader in complex generics, enabling affordable medicines globally.

• Complex generic pharmaceuticals

  Synthon specializes in the development, manufacturing and commercialization of complex generic pharmaceuticals globally.

1. 1Synthon | Science. People. Affordable medicines.synthon.com
2. 2Commercialization | Synthon | Science. People. Affordable medicines.synthon.com
3. 3About Synthon | Synthon | Science. People. Affordable medicines.synthon.com
4. 4ESG | Synthon | Science. People. Affordable medicines.synthon.com